Abortion Pills

86 Pages Posted: 26 Jan 2023 Last revised: 1 Mar 2024

See all articles by David S. Cohen

David S. Cohen

Drexel University Thomas R. Kline School of Law

Greer Donley

University of Pittsburgh - School of Law

Rachel Rebouché

Temple University - James E. Beasley School of Law

Date Written: February 29, 2024

Abstract

Abortion is now illegal in roughly a third of the country, but abortion pills are more widely available than ever before. Clinics, websites, and informal networks facilitate the distribution of abortion pills, legally and illegally, across the United States, while antiabortion advocates and legislators are adopting all manner of strategies to attack pills. This Article is the first in the legal literature to explore this defining aspect of this new environment and the novel issues it raises at the level of state law, federal policy, and on-the-ground advocacy.

The Article begins by detailing anti-abortion strategies to stop pills by any means necessary. These tactics include a federal lawsuit attacking the approval and regulation of mifepristone, one of two abortion pills; a revival of the long-unenforced Comstock Act’s ban on mailing anything that induces an abortion; a redefinition of abortion’s location to chill the provision of medication abortion; attacks on online information and pill supply chains; and attempts to target both those who take abortion pills and those who help others access them. We then consider the opposing movement to increase access to abortion pills: abortion shield laws that protect cross-border telehealth, efforts to evade abortion bans through missed period pills and advance provision, and pharmacist prescribing of abortion pills. Finally, we examine how the U.S. Food and Drug Administration (FDA) can use its powers to increase or decrease access to pills, including lifting the unnecessary restrictions on medication abortion, changing the pills’ labels, or asserting that FDA rules governing medication abortion partially preempt state abortion bans.

The Article concludes by offering the first analysis of how, after Roe’s reversal, abortion pills and their attendant controversies are transforming the abortion debate in this country. With pills, state governments and the medical establishment will lose even more control over abortion; rather, informal and underground networks will meet much of the demand for abortion pills, cutting out gatekeepers. The wide availability of pills will also reshape the definition of abortion—which is ill-suited for the ambiguities of drug provision—and could destigmatize abortion care. At the same time, however, attempts to punish people who provide or use pills will exacerbate the public health and criminal justice consequences that new abortion bans have wrought, entrenching existing class and race disparities. Thus, as abortion pills proliferate—both within and outside of law— abortion inequities could as well. Ultimately, these emerging legal issues will profoundly alter how people think about abortion.

Keywords: Dobbs, Roe, Pills, Medication Abortion, Abortion, Mifepristone, Alliance for Hippocratic Medicine

Suggested Citation

Cohen, David S. and Donley, Greer and Rebouche, Rachel, Abortion Pills (February 29, 2024). 76 Stanford Law Review 317 (2024), U. of Pittsburgh Legal Studies Research Paper No. 2023-12, Available at SSRN: https://ssrn.com/abstract=4335735 or http://dx.doi.org/10.2139/ssrn.4335735

David S. Cohen (Contact Author)

Drexel University Thomas R. Kline School of Law ( email )

3320 Market Street
Philadelphia, PA 19104
215-571-4714 (Phone)

Greer Donley

University of Pittsburgh - School of Law ( email )

3900 Forbes Ave.
Pittsburgh, PA 15260
United States

HOME PAGE: http://www.law.pitt.edu/people/greer-donley

Rachel Rebouche

Temple University - James E. Beasley School of Law ( email )

1719 N. Broad Street
Philadelphia, PA 19122
United States

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
3,369
Abstract Views
13,010
Rank
6,604
PlumX Metrics